IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.314
-0.007 (-2.09%)
Apr 28, 2026, 4:00 PM EDT - Market closed
IGC Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IGC Pharma stock has a target of 5.25, which predicts an increase of 1,574.64% from the current stock price of 0.31.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for IGC Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $5.25 | Strong Buy | Maintains | $5 → $5.25 | +1,574.64% | Apr 8, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.75 → $5 | Strong Buy | Maintains | $4.75 → $5 | +1,494.90% | Feb 23, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.5 → $4.75 | Strong Buy | Maintains | $4.5 → $4.75 | +1,415.15% | Dec 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,335.41% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,016.43% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
1.12M
from 1.27M
Decreased by -12.04%
Revenue Next Year
1.26M
from 1.12M
Increased by 13.06%
EPS This Year
-0.08
from -0.09
EPS Next Year
-0.08
from -0.08
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.4M | 1.6M |
| Avg | 1.1M | 1.3M |
| Low | 891,800 | 981,960 |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 7.6% | 40.9% |
| Avg | -12.0% | 13.1% |
| Low | -29.8% | -12.2% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.08 | -0.07 |
| Avg | -0.08 | -0.08 |
| Low | -0.08 | -0.09 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.